Cargando…
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Acute lymphoblastic leukemia (ALL) is an aggressive hematological tumor resulting from the malignant transformation of lymphoid progenitors. Despite intensive chemotherapy, 20% of pediatric and over 50% of adult ALL patients fail to achieve a complete remission or relapse after intensified chemother...
Autores principales: | Tzoneva, Gannie, Garcia, Arianne Perez, Carpenter, Zachary, Khiabanian, Hossein, Tosello, Valeria, Allegretta, Maddalena, Paietta, Elisabeth, Racevskis, Janis, Rowe, Jacob M., Tallman, Martin S., Paganin, Maddalena, Basso, Giuseppe, Hof, Jana, Kirschner-Schwabe, Renate, Palomero, Teresa, Rabadan, Raul, Ferrando, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594483/ https://www.ncbi.nlm.nih.gov/pubmed/23377281 http://dx.doi.org/10.1038/nm.3078 |
Ejemplares similares
-
Clonal evolution mechanisms in NT5C2 mutant relapsed acute lymphoblastic leukemia
por: Tzoneva, Gannie, et al.
Publicado: (2018) -
Recurrent mutations in epigenetic regulators, RHOA
and FYN kinase in peripheral T cell lymphomas
por: Palomero, Teresa, et al.
Publicado: (2014) -
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL
por: Gatta, Giusy Della, et al.
Publicado: (2012) -
ParMap, an algorithm for the identification of small genomic insertions and deletions in nextgen sequencing data
por: Khiabanian, Hossein, et al.
Publicado: (2010) -
ETV6 mutations in early immature human T cell leukemias
por: Van Vlierberghe, Pieter, et al.
Publicado: (2011)